SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Capgemini SE (CGEMY) trades at a trailing P/E of 14.0, forward P/E of 9.7. Trailing earnings yield is 7.12%, forward earnings yield 10.36%. PEG 0.21 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (14.0); PEG ≤ 1.0 — Peter Lynch undervalued (0.21); earnings yield beats bond yields (7.12%).
- Forward P/E 9.7 (down from trailing 14.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.21 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 7.12% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 10.36% as earnings recover.
Overall SharesGrow Score: 55/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CGEMY
Valuation Multiples
P/E (TTM)14.0
Forward P/E9.7
PEG Ratio0.21
Forward PEG0.21
P/B Ratio0.00
P/S Ratio1.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.75
Forward EPS (Est.)$2.55
Book Value / Share$0.00
Revenue / Share$24.61
FCF / Share$0.00
Yields & Fair Value
Earnings Yield7.12%
Forward Earnings Yield10.36%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.21 |
$12.54B |
$921M |
7.3% |
| 2017 |
$0.19 |
$12.79B |
$820M |
6.4% |
| 2018 |
$0.17 |
$13.2B |
$730M |
5.5% |
| 2019 |
$1.00 |
$14.13B |
$856M |
6.1% |
| 2020 |
$1.11 |
$15.85B |
$957M |
6% |
| 2021 |
$1.33 |
$18.16B |
$1.16B |
6.4% |
| 2022 |
$1.76 |
$22B |
$1.55B |
7% |
| 2023 |
$0.34 |
$22.52B |
$1.66B |
7.4% |
| 2024 |
$1.89 |
$22.1B |
$1.67B |
7.6% |
| 2025 |
$1.75 |
$21.58B |
$1.54B |
7.1% |
